Onderneming Ceapro Inc Toronto S.E.
Aandelen
CZO
CA1499071076
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 01-01-07 |
Director of Finance/CFO | - | 05-05-15 | |
Mitch Regnier
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-23 |
Paul Moquin
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-18 |
Chief Tech/Sci/R&D Officer | - | 01-01-10 | |
General Counsel | - | - | |
Leoni DeJoya
PRN | Corporate Officer/Principal | - | 07-01-19 |
52 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 01-01-07 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 27-04-15 |
William Li
BRD | Director/Board Member | 61 | 20-11-14 |
Ronald Miller
CHM | Chairman | - | 02-03-22 |
Geneviève Foster
BRD | Director/Board Member | - | 19-04-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 78 293 177 | 76 755 900 ( 98,04 %) | 0 | 98,04 % |
Bedrijfsgegevens
![Adres Ceapro Inc(CZO)](https://cdn.zonebourse.com/static/address/1409692.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,15% | 46,55 mld. | |
+45,94% | 41,84 mld. | |
-2,37% | 40,84 mld. | |
+33,84% | 32,95 mld. | |
-6,35% | 28,27 mld. | |
+20,42% | 27,78 mld. | |
+48,83% | 14,26 mld. | |
+45,00% | 13,69 mld. | |
+0,06% | 12,18 mld. |